Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The shifts werent merely numerical
doi: 10.1111/j.1463-1318.2012.02926.x 43 NaseerMPoolaSAliSSamiullahSTahanV
Primary Handling Editor: Sonia Muliyil, in collaboration with the Nature Medicine team
Clinical role is as an adjunct rather than primary therapy
GLP-1 Drug Semaglutide (Ozempic, Wegovy) Reduced Heavy Drinking & Craving in Adults with Alcohol Use Disorder A preliminary, phase 2 clinical trial has shown the potential benefit of a class of popular medications so far approved for control of diabetes and obesity to help reduce alcohol consumption and craving in individuals with alcohol use disorder (AUD)
US$ 27.56
US$ 24.94
US$ 21.24
US$ 23.52
